Evidence map›Paper›PMID 42243120›Full record

ArticleNature communications2026

Antioxidant lipid nanoparticles enhance mRNA stability for regeneration therapy and gene editing.

Benhao Li, Mengyao Zhao, Bowei Yang, Taihua Yang, Yongling Wang, Yaxin Hu, Miao Zhang, Jiahao Ge, Xianglong Tang, Ze Zhang and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Benhao Li *Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Mengyao Zhao *Laboratory of Advanced Materials, College of Smart Materials and Future Energy (iCOME), Fudan University, Shanghai, China. myzhao@fudan.edu.cn.ORCID http://orcid.org/0000-0003-2238-6875
Bowei YangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0009-0000-4136-3084
Taihua YangDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yongling WangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Yaxin HuDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Miao ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jiahao GeDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xianglong TangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ze ZhangDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Hengqing CuiDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Xiaoyuan ChenCenter for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan, China.ORCID http://orcid.org/0000-0002-9622-0870
Yi Yan YangBioprocessing Technology Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-1871-5448
Ling PengCentre Interdisciplinaire de Nanoscience de Marseille, Aix-Marseille Universite, CNRS, UMR 7325, ́ "Equipe Labellisee Ligue Contre le Cancer", Marseille, France.ORCID http://orcid.org/0000-0003-3990-5248
Qianqian NiDepartment of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. qqian.ni@nus.edu.sg.ORCID http://orcid.org/0000-0003-4230-5059

Funding

National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore) CRP28-2022RS-0001
6 · The paper itself

Abstract

The success of mRNA vaccines has motivated the development of mRNA therapeutics to treat a wide range of diseases, as well as applications in regenerative medicine. However, the inherent instability of mRNA under conditions of oxidative stress renders these applications challenging. Here we report a general approach to shield mRNA from oxidative degradation by incorporating antioxidant lipid within lipid nanoparticles (LNPs). Specifically, we design a library of antioxidant ionizable lipids and identify a lead LNP formulation containing a 4-hydroxyphenyl-modified antioxidant lipid. Mechanistically, we show that antioxidant LNPs directly scavenge reactive species and preserve mRNA integrity under extracellular and intracellular oxidative stress. Across multiple organ and tissue injury models, we demonstrate that AO

Indexed as

AntioxidantsGene EditingLipidsNanoparticlesRegenerationRNA, MessengerRNA StabilityAnimalsHumansLiposomesMiceOxidative StressRegenerative MedicineAntioxidantsLipid NanoparticlesLipidsLiposomesRNA, Messenger

Identifiers

PMID42243120
PMCPMC13396230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.